Tenet Healthcare (THC) Current Deferred Revenue (2019 - 2023)

Tenet Healthcare has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $86.0 million for Q3 2023.

• Current Deferred Revenue for Q3 2023 came in at $86.0 million, down 22.52% year-over-year; the trailing twelve-month figure through Sep 2023 was $86.0 million (down 22.52% YoY), and the FY2022 annual result was $110.0 million, down 87.44% from the prior year.
• Current Deferred Revenue came in at $86.0 million for Q3 2023 at Tenet Healthcare, up from $76.0 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.3 billion in Q2 2020 to a low of $56.0 million in Q4 2020.
• The 5-year median for Current Deferred Revenue is $98.0 million (2021), against an average of $287.6 million.
• Peak annual rise in Current Deferred Revenue reached 1677.59% in 2021, while the deepest fall reached 91.63% in 2021.
• Tenet Healthcare's Current Deferred Revenue stood at $72.0 million in 2019, then fell by 22.22% to $56.0 million in 2020, then soared by 1464.29% to $876.0 million in 2021, then tumbled by 87.44% to $110.0 million in 2022, then slipped by 21.82% to $86.0 million in 2023.
• The last three Current Deferred Revenue figures came in at $86.0 million (Q3 2023), $76.0 million (Q2 2023), and $76.0 million (Q1 2023), per Business Quant data.